The pharma market access conferences worth a commercial team's time in 2026 share one trait: they put market access, HEOR, and medical affairs leaders in the same room as the payers and health system executives who actually control access.
Reaching prescribers is not the same as winning system adoption, and the events below are where that second, harder conversation…
AI has moved beyond proof-of-concept on the clinical side of pharma, driving rapid discovery of new molecules. But post-market commercialization teams tell a different story: their boards are asking them to use AI to solve the problems caused by multiple rounds of layoffs, mounting pressure to do more with less, and a human capital fabric…
Next Pharma Summit is a 2-day, multi-stage conference for pharma professionals passionate about Digital, Commercial, Medical Affairs, AI, Technology, and beyond. As pharma rapidly redefines its purpose, NEXT brings together cross-functional leaders to foster smarter collaboration and create meaningful impact for customers, HCPs, and patients. One simple question guides us: Where to NEXT? Use…
Shots:
Mohamed Eid, VP of Clinical Development & Medical Affairs, Cardio-Renal-Metabolism & Respiratory Medicine, at Boehringer Ingelheim, in a stimulating conversation with PharmaShots sheds light on the recent approval of Jardiance for the treatment of adults with chronic kidney disease
Jardiance’s EMPA Kidney P-III trial results demonstrated a 28% relative risk reduction vs placebo. Jardiance…
Medical Affairs is a critical scientific bridge between Healthcare companies and their internal & external stakeholders. It plays a leadership role in implementing cutting-edge medical, scientific, and patient-centered insights & solutions that drive strategy and innovation in healthcare. The healthcare ecosystem is dynamic and being transformed with the latest tech solutions. It is believed that in…

